25 patents
Page 2 of 2
Utility
Modified Relaxin Polypeptides and Their Uses
18 Nov 20
Modified relaxin polypeptides and their uses thereof are provided.
Vadim KRAYNOV, Nick KNUDSEN, Amha HEWET, Kristine DE DIOS, Jason PINKSTAFF, Lorraine SULLIVAN
Filed: 26 May 20
Utility
Modified Relaxin Polypeptides and Their Uses
18 Nov 20
Modified relaxin polypeptides and their uses thereof are provided
Vadim KRAYNOV, Nick KNUDSEN, Amha HEWET, Kristine DE DIOS, Jason PINKSTAFF, Lorraine SULLIVAN
Filed: 27 May 20
Utility
Antibody Drug Conjugate for Anti-inflammatory Applications
27 May 20
Antibody drug conjugates (ADCs) comprising an antibody conjugated to an anti-inflammatory therapeutic agent via a phosphate-based linker with tunable extracellular and intracellular stability are described.
Philip E. Brandish, Robert M Garbaccio, Jeffrey Kern, Linda Liang, Sanjiv Shah, Dennis Zaller, Andrew Beck, Dennis Gately, Nick Knudsen, Anthony Manibusan, Jianing Wang, Ying Sun
Filed: 29 Sep 16
Utility
Modified FGF-21 Polypeptides and Their Uses
29 Jan 20
Modified FGF-21 polypeptides and uses thereof are provided.
Thomas P. CUJEC, Roberto MARIANI, Anna-Maria A. HAYS PUTNAM, William M. KEEFE, Nick KNUDSEN, Lillian SKIDMORE, Jason PINKSTAFF, Vadim KRAYNOV
Filed: 16 Jun 19
Utility
ANTI-CD70 Antibody Drug Conjugates
6 Nov 19
This invention relates to anti-CD70 antibodies and antibody drug conjugates comprising at least one non-naturally-encoded amino acid.
Richard S. Barnett, Nick Knudsen, Ying Sun, Sandra Biroc, Timothy Buss, Tsotne Javahishvili, Damien Bresson, Shailaja Srinagesh, Amha Hewet, Jason Pinkstaff
Filed: 17 Dec 18